XSPRAY — XSpray Pharma AB (publ) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for XSpray Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	326	272	120	166	208
Net Total Accounts Receivable
Net Total Receivables	2.67	2.5	2.58	4.17	4.02
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	331	282	132	218	235
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	42.7	44.6	64.6	108	79.2
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	605	623	585	765	796
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.8	30	28.9	39.9	146
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.7	31.2	29.4	71.8	173
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	583	592	556	693	623
Total Liabilities & Shareholders' Equity	605	623	585	765	796
Total Common Shares Outstanding